GL Pharm Tech Corp. (KOSDAQ:204840)
924.00
-31.00 (-3.25%)
At close: Jun 1, 2026
GL Pharm Tech Market Cap
GL Pharm Tech has a market cap or net worth of 71.66 billion as of June 1, 2026. Its market cap has decreased by -32.04% in one year.
Market Cap
71.66B
Enterprise Value
89.13B
Revenue
36.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
924.00
Market Cap Chart
Since September 20, 2016, GL Pharm Tech's market cap has increased from 31.01B to 71.66B, an increase of 131.11%. That is a compound annual growth rate of 9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 74.06B | -12.47% |
| Dec 30, 2025 | 84.61B | 12.66% |
| Dec 30, 2024 | 75.10B | 6.02% |
| Dec 28, 2023 | 70.83B | 52.08% |
| Dec 29, 2022 | 46.58B | -39.27% |
| Dec 30, 2021 | 76.70B | 12.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 97.27B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 91.75B |
| Sam-A Pharm. | 88.56B |
| Polaris AI Pharma | 84.88B |
| Daehan Nupharm | 83.93B |
| Pharos iBio | 81.56B |
| Sinsin Pharmaceutical | 76.46B |
| Optipharm.CO.,LTD | 69.76B |